Fusion glycoprotein F0/F protein (RSV) Product List
Host Species
- Mouse（2）
Conjugate
- Unconjugated（2）
Reactive Species
- Virus（2）
Applications
- ELISA（2）
| Molecule | Cat. No. | Product Name | Host Species | Reactive Species | Applications | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|
| Fusion glycoprotein F0/F protein (RSV) | Monoclonal Anti-HRSV F Antibody, Human IgG1 (4D7) |  Mouse | Virus | $415.00 100ug |   | ||
| Fusion glycoprotein F0/F protein (RSV) | Monoclonal Anti-Fusion glycoprotein F0 Antibody, Mouse IgG2a (101F) | Mouse | Virus | $415.00 100ug | |
You Have Viewed 1-2 Of 2 Results
Asset Licensing Opportunity
Resources
Clinical Drug Information
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Galunisertib | LY-2157299 | Phase 2 Clinical | Eli Lilly And Company | Breast Neoplasms; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Glioma; Peritoneal Neoplasms; Colorectal Neoplasms; Nasopharyngeal Carcinoma; Prostatic Neoplasms; Solid tumours; Neoplasms; Myelodysplastic Syndromes; Glioblastoma; Triple Negative Breast Neoplasms; Pancreatic Neoplasms; Carcinoma, Renal Cell; Rectal Neoplasms; Liver Neoplasms | Details |
| GF-101 | GFH-018; GF-101; GFH018 | Phase 2 Clinical | Genfleet Therapeutics (Shanghai) Inc | Solid tumours; Liver Neoplasms; Pancreatic Neoplasms; Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung | Details |
| ORG-129 | ORG-129; AGMB-129 | Phase 2 Clinical | Origo Biopharma Sociedad Litmitada | Crohn Disease | Details |
| TRK-250 | TRK-250; BNC-1021 | Phase 1 Clinical | Bonac Corp | Idiopathic Pulmonary Fibrosis | Details |
| Itacnosertib | TP-0184 | Phase 1 Clinical | Tolero Pharmaceuticals Inc, Sumitomo Dainippon | Solid tumours; Anemia | Details |
| Oxinseti | SH-3051 | Phase 1 Clinical | Nanjing Sanhome Pharmaceutical Co Ltd | Solid tumours; Liver Neoplasms | Details |
| AGMB-447 | AGMB-447; ORG-447 | Phase 1 Clinical | AgomAb Therapeutics NV | Idiopathic Pulmonary Fibrosis | Details |
| TD-1058 | Phase 1 Clinical | Theravance Biopharma Inc | Idiopathic Pulmonary Fibrosis | Details |
Customer Reviews